| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
5e-07 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.2 |
6e-05 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |